The Healthcare Economy and Challenges Faced in Procurement – How Greiner Bio-One Helps
laatst gewijzigd: | Op waarde gebaseerde inkoop - Terug naar overzicht
The healthcare market sector is incredibly dynamic and if we have learnt anything from the past few years, then it is that manufacturers need to be able to react fast when called upon. As we have read in a previous article (Why strategic partnerships with suppliers are key to a successful procurement strategy), if the usual supply chain breaks down, a purchaser in a clinical healthcare setting may be forced to make on-the-spot decisions to ensure that sufficient supplies and materials are available to prevent daily operations from being interrupted and maintaining the provision of healthcare.
Of course, a pandemic situation certainly does not promote sustainable actions. When acute care becomes the primary concern, emergencies have to be dealt with immediately since immediate action can literally be the difference between life and death.
Why Greiner Bio-One plays an active role!
Decision making in a dynamic, fast paced environment with the additional burden that these decisions may in further consequence have an influence on the health and wellbeing of a person in the care of your facility is an enormous responsibility.
Greiner Bio-One, as a leading manufacturer in the medical device sector, plays an active role in helping customers to shoulder this burden.
During the pandemic, amongst an atmosphere of fear and panic due to uncertainty and shortages, it became clear that to enable the essential faster reaction times, it was necessary to bring all teams involved in daily operations closer, meaning from point of contact with the customer to supply chain and logistics, and not just at the headquarters, but on a global basis. It was at this time that the concept of a constantly updated KPI (key performance indicators) dashboard as well as a global S&OP (Sales and Operation Planning) was initiated.
This enabled monitoring and transparency of daily operational business as well as aligned sales and supply plans for critical product groups through a global lens. To ensure the best possible supply to customers worldwide, the dashboard gave an overview of the whole value chain, from the incoming orders, enabling continuous analysis of customer and market needs, up to the production output and any backorder situation, providing immediate identification of pain points.
Greiner Bio-One: A competent and trusted partner
A system born in a time of crisis has developed into a highly intelligent system still in use today and still being perfected and improved on. This makes Greiner Bio-One an extremely competent and trusted partner in the healthcare sector. With the KPI dashboard, fed by information from all of Greiner Bio-One’s global facilities, market trends and reactions are recognized ahead of time, enabling an understanding of why interest in certain product lines are developing or diminishing. With this tool, Greiner Bio-One has the capacity to better monitor a market situation and evaluate if questions need to be asked. For example, if an epidemic is reported, that may cause fear, resulting in sudden bulk buying, or acute additional needs, for example. This order behaviour analysis means that the most suitable operational measures can be derived on a daily basis, whether that be to switch focus on a particular product or to ramp down others and even enabled production planning across continents. Global cooperation is fostered, and risk management is increasingly better aligned.
Greiner Bio-One Preanalytics has production facilities on continents across the world, in Austria, USA, Brazil and Thailand, as well as warehouse facilities at sales subsidiaries in many countries. Greiner Bio-One has always highly valued these short supply and localized delivery paths and in providing this supply network, Greiner Bio-One has been a pioneer in keeping their carbon footprint as low as possible.
However, a crucial lesson from the past few years has been to consider the balance between preservation of the environment and being in a position to ensure lean reactions to adverse medical situations. The global KPI dashboard has meant that global subsidiaries have been able to support each other at times of shortage and emergency, serving customers in the healthcare industry when the need is most acute.
Greiner Bio-One will continue to analyse and optimize operations, ensuring that as far as possible the environmental footprint remains a priority alongside efficient supply and benefit to customers.
Neem het zekere voor het onzekere
Ontvang alle relevante informatie over het onderwerp veiligheid tijdens bloedafname!
Vind de juiste contacpersoon/-adres voor het versturen van een aanvraag
Disclaimer
Deze productinformatie is uitsluitend bestemd voor professionals in de gezondheidszorg. Hulpmiddelen van Greiner Bio-One mogen uitsluitend worden gebruikt door goed opgeleide beroepsbeoefenaren in de gezondheidszorg in overeenstemming met de betreffende gebruiksaanwijzing (IFU). Voor een opsomming van indicaties, contra-indicaties, voorzorgsmaatregelen en waarschuwingen wordt verwezen naar de gebruiksaanwijzing die bij elk product wordt geleverd of kan worden gedownload van onze website www.gbo.com (Download Center). Neem voor meer informatie contact op met uw lokale Greiner Bio-One vertegenwoordiger of bezoek onze website.
Alle informatie wordt ondanks zorgvuldige verwerking zonder garantie verstrekt. Elke aansprakelijkheid, garantie of waarborg van Greiner Bio-One GmbH is uitgesloten. Alle rechten, fouten en wijzigingen zijn voorbehouden. Voor zover niet anders vermeld, bezit Greiner Bio-One GmbH alle auteursrechten en/of andere (gebruiks)rechten op deze documenten, in het bijzonder op tekens zoals de genoemde (woord-)merken en logo's. Elk gebruik, verveelvoudiging of ander gebruik van de rechten van Greiner Bio-One GmbH is uitdrukkelijk verboden.
Testimonials op deze blog geven individuele ervaringen weer over het gebruik van onze producten en/of diensten. De in deze publicatie geuite meningen zijn die van de geïnterviewde; zij zijn niet bedoeld om de meningen of standpunten van Greiner Bio-One.
Media owner and publisher: Greiner Bio-One GmbH, Bad Haller Str. 32, 4550 Kremsmünster
